Skip to Content
Gregory K Hartig, MD

Contact Dr. Hartig

E-mail:
hartig@surgery.wisc.edu

Phone:
(608) 265-8207

Mail:
600 HIGHLAND AVE
MC 7375
MADISON, WI 53792-3284

Gregory K Hartig, MD

Professor
Chief, Section of Head and Neck Surgical Oncology
Division of Otolaryngology-Head & Neck Surgery

Education

  • MD, University of Michigan, Ann Arbor, MI, 1988
  • Internship, St. Joseph Mercy Hospital, Ann Arbor, MI, 1988-1989
  • Residency, University of Michigan, Ann Arbor, MI, 1989-1993
  • Fellow, Head and Neck Reconstructive Surgery, University of Pennsylvania Medical Center, Philadelphia, PA, 1993-1994

Clinical Specialties

Dr. Hartig is certified by the American Board of Otolaryngology-Head and Neck Surgery. His practice combines traditional head and neck surgery with facial plastic and reconstructive surgery. He has extensive experience managing head and neck cancer, including tumors of the skull base, and performing microvascular free tissue transfer reconstruction. Dr. Hartig directs the head and neck oncology program at UW Hospital and Clinics.

Dr. Hartig provides a wide range of services including Airway Dilation, Airway Reconstruction, Endoscopic Partial Laryngectomy, Esophageal Dilation, Free Flap, Free Tissue Transfer, Functional Neck Dissection, Laryngeal Surgery, Laser Procedures, Leukoplakia Laser Treatment, Maxilofacial Trauma Repair, Open Partial Laryngectomy, Thyroidectomy, Thyroid Lobectomy, Thyroid Surgery, Total Laryngectomy, Total Thyroidectomy, Tracheostomy, and Transoral Robotic Surgery.

Research Interests

Dr. Hartig has research interests in the cytogenetics of head and neck carcinoma, free flap physiology, and airway reconstruction.

Recent Publications
  • Chondroradionecrosis of the larynx: 24-year University of Wisconsin experience.
    Gessert TG, Britt CJ, Maas AM, Wieland AM, Harari PM, Hartig GK
    Head Neck 2017 Mar 11.
    [PubMed ID: 28295829]
    More Information
  • Defining the boundaries and expanding the utility of head and neck cancer patient derived xenografts.
    Swick AD, Stein AP, McCulloch TM, Hartig GK, Ong IM, Sampene E, Prabakaran PJ, Liu CZ, Kimple RJ
    Oral Oncol. 2017 Jan; 64():65-72.
    [PubMed ID: 28024726, PMC ID: 5218527]
    More Information
  • Patient-Derived Adenoid Cystic Carcinoma Xenografts to Examine Personalized Radiation Therapy.
    Prabakaran P, Swick AD, Nickel KP, Yang DT, Werner L, Bruce JY, Wieland A, McCulloch TM, Hartig GK, Harari PM, Kimple RJ
    Int. J. Radiat. Oncol. Biol. Phys. 2016 Oct 1; 96(2S):S214.
    [PubMed ID: 27675814]
    More Information
  • Risk factors for unplanned readmission following head and neck microvascular reconstruction: Results from the National Surgical Quality Improvement Program, 2011-2014.
    Garg RK, Wieland AM, Hartig GK, Poore SO
    Microsurgery 2016 Sep 23.
    [PubMed ID: 27658935]
    More Information
  • Assessing p16 Status of Oropharyngeal Squamous Cell Carcinoma by Combined Assessment of the Number of Cells Stained and the Confluence of p16 Staining: A Validation by Clinical Outcomes.
    Barasch S, Mohindra P, Hennrick K, Hartig GK, Harari PM, Yang DT
    Am. J. Surg. Pathol. 2016 Sep; 40(9):1261-9.
    [PubMed ID: 27186851, PMC ID: 4987254]
    More Information

webmaster@surgery.wisc.edu Copyright © 2017 The Board of Regents of the University of Wisconsin System